Ohta Masaru, Takeshita Iwao, Matsumoto Kenichi, Matsuoka Shiro, Ikeda Kimiaki
Department of Neurosurgery, Kyusyu Rosai Hospital, Kitakyusyu-shi, Fukuoka, Japan.
No Shinkei Geka. 2005 Mar;33(3):263-8.
We report a case of primary central nervous system lymphoma (PCNSL) who responded well to initial systemic chemotherapy, but subsequently developed breast metastasis with local recurrence in the brain 27 months after complete remission. The 53-year-old female suddenly felt weakness in her left extremity. She was transferred to the emergency ward in our hospital. Neurological examination on admission showed disorientated state and mild hemiparesis. Brain MRI showed a well enhanced round lesion in the right basal ganglia with perifocal edema. A stereotactic biopsy of the tumor made a diagnosis of classic diffuse non-Hodgkin's B-cell type lymphoma. She received chemotherapy with a high-dose methotrexate under a condition of 20% of Karnofsky Performance Status (KPS). She enjoyed a useful life for about 5 years (KPS; 60-70%). Both recurrent and metastatic lesions responded poorly to various aggressive multiagent regimens of chemotherapy. An intensive initial treatment for the primary lesion and closely monitoring of the whole body at regular intervals are necessary for ensuring a long useful life.
我们报告一例原发性中枢神经系统淋巴瘤(PCNSL)患者,该患者对初始全身化疗反应良好,但在完全缓解27个月后出现脑内局部复发并伴有乳腺转移。这位53岁女性突然感到左侧肢体无力,被转诊至我院急诊病房。入院时神经系统检查显示意识模糊状态和轻度偏瘫。脑部MRI显示右侧基底节有一个强化良好的圆形病灶,周围有水肿。对肿瘤进行立体定向活检,诊断为经典弥漫性非霍奇金B细胞型淋巴瘤。她在卡氏功能状态(KPS)为20%的情况下接受了大剂量甲氨蝶呤化疗。她维持了约5年的有效生存期(KPS为60 - 70%)。复发和转移病灶对各种积极的多药联合化疗方案反应不佳。为确保较长的有效生存期,对原发性病灶进行强化初始治疗并定期密切监测全身是必要的。